ロード中...
A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults
BACKGROUND: This phase I trial evaluated the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime-MVA85A boost, previously demonstrated to be protective in animal studies, in healthy UK adults. METHODS: We enrolled 42 healthy, BCG-vaccinated adults into 4 grou...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Science
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6985898/ https://ncbi.nlm.nih.gov/pubmed/31735500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.10.102 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|